← All trials
NCT03643627
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 17, 2016
- Primary completion
- Apr 13, 2017
- Completion date
- Apr 13, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 31
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Syntimmune, Inc.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.